Advertisement vbandhakavi, Author at Pharmaceutical Business review - Page 9 of 159
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

All articles by vbandhakavi 

Omeros gets FDA Orphan Drug Designation for PNH therapy

The investigational human monoclonal antibody, OMS906 targets mannan-binding lectin-associated serine protease-3 (MASP-3), the main activator of the alternative pathway of the complement system. MASP-3 converts pro-complement factor D